• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Haemonetics Corp (NY: HAE )

    87.66 +1.44 (+1.67%)
    Official Closing Price Updated: 4:10 PM EDT, Apr 25, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 431,156
    Open 85.76
    Bid (Size) 83.01 (1)
    Ask (Size) 89.00 (2)
    Prev. Close 86.22
    Today's Range 84.45 - 87.76
    52wk Range 70.74 - 95.26
    Shares Outstanding 51,029,618
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering.
    For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering. 
    Via Chartmill
    Earnings Scheduled For February 8, 2024
    Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
    Via Benzinga

    Performance

    YTD
    +2.96%
    +2.96%
    1 Month
    +7.14%
    +7.14%
    3 Month
    +7.19%
    +7.19%
    6 Month
    +3.18%
    +3.18%
    1 Year
    +5.44%
    +5.44%

    More News

    Read More
    Intuitive Surgical Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
    Via Investor's Business Daily
    Intuitive Surgical Stock Rating Climbs As Sales, Profits Rise
    Via Investor's Business Daily
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Is HAEMONETICS CORP/MASS (NYSE:HAE) suited for quality investing?
    Via Chartmill
    Exploring NYSE:HAE's quality characteristics.
    Via Chartmill
    Should you consider NYSE:HAE for quality investing?
    Via Chartmill
    4 Analysts Have This to Say About Haemonetics
    Via Benzinga
    Intuitive Surgical Stock Nearly Doubles; Gets Rating Upgrade
    Via Investor's Business Daily
    Haemonetics Earnings Preview
    Via Benzinga
    Haemonetics Corp. (NYSE: HAE) Making Surprising Moves in Monday Session
    Via Investor Brand Network
    Haemonetics Q4 Earnings Exceed Expectations On Volume And Price Benefits
    Via Benzinga
    Recap: Haemonetics Q4 Earnings
    Via Benzinga
    Looking Into Haemonetics's Return On Capital Employed
    Via Benzinga
    Alphabet To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Wednesday
    Via Benzinga
    Earnings Preview: Haemonetics
    Via Benzinga
    Where Haemonetics Stands With Analysts
    Via Benzinga
    9 Analysts Have This to Say About Haemonetics
    Via Benzinga
    Incyte, Haemonetics Post Earnings Beats; One Surges Within Buy Zone
    Via Investor's Business Daily
    How 2022's Biggest Healthcare Gainers Could Fare In 2023
    Via MarketBeat
    InMode Stock Shows Improved Technical Strength; Hits Key Technical Threshold
    Via Investor's Business Daily
    Analysts Take Bullish Stance On Haemonetics, Cites Plasma Momentum As Catalyst
    Via Benzinga
    Haemonetics: Q2 Earnings Insights
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.